ST
Healthcare & Life Sciences
SCAI Therapeutics
South Koreascaitrx.com
SCAI Therapeutics is a Healthcare & Life Sciences startup based in South Korea, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About SCAI Therapeutics
SCAI Therapeutics is a company headquartered in South Korea. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
SCAI Therapeutics is a biotechnology company focused on developing innovative drug and cosmetic solutions by overcoming limitations in molecular innovation.
Explore SCAI Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.